Endometrial Serous Carcinoma: Its Molecular Characteristics and Histology-Specific Treatment Strategies
Open Access
- 6 August 2012
- Vol. 4 (3), 799-807
- https://doi.org/10.3390/cancers4030799
Abstract
Endometrial cancer is the fourth most common malignancy in women, with most cases being classified as early stage endometrioid tumors that carry a favorable prognosis. The endometrial serous histological subtype (ESC), however, while only accounting for 10% of all endometrial cancers is responsible for a disproportionate number of deaths. Unlike the estrogen-dependent, well differentiated endometrioid tumors, which are commonly associated with a younger age of onset, ESCs are estrogen-independent and tend to present at an advanced stage and in older women. Treatment for ESC entails aggressive surgery and multimodal adjuvant therapy. In this review, we describe the clinical behavior, molecular aspects, and treatment strategies for ESC.Keywords
This publication has 34 references indexed in Scilit:
- Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid CarcinomaThe American Journal of Surgical Pathology, 2011
- ARID1AMutations in Endometriosis-Associated Ovarian CarcinomasNew England Journal of Medicine, 2010
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancerInternational Journal of Clinical Oncology, 2010
- Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: A phase II study of the Gynecologic Oncology GroupGynecologic Oncology, 2006
- Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosisLaboratory Investigation, 2006
- Minimal uterine serous carcinoma: a clinicopathological study of 40 casesLaboratory Investigation, 2005
- Uterine serous and grade 3 endometrioid carcinomasCancer, 2004
- Noninvasive papillary serous carcinoma of the endometriumPublished by Ovid Technologies (Wolters Kluwer Health) ,2001
- Intravenous Cisplatin, Doxorubicin, and Cyclophosphamide in the Treatment of Uterine Papillary Serous Carcinoma (UPSC)Gynecologic Oncology, 1993